文献速递腹部MR

MRI有助于提示和排除胰腺黏液性囊性肿瘤的恶性变

MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas.
PubMed 文献 · Eur Radiol · 2021-08-10

该回顾性单中心研究纳入63例切除的胰腺黏液性囊性肿瘤(MCN),由两名阅片者独立盲法评估MRI。联合T2WI信号不均匀、壁厚≥5mm、壁结节≥9mm及强化分隔四个特征诊断恶性MCN的AUC为0.97(95%CI 0.91-1.00)。无强化分隔或壁、壁厚<3mm及无壁结节对良性MCN有很高的阴性预测值。

要点

  • 联合T2WI信号不均匀、壁厚≥5mm、壁结节≥9mm、强化分隔提示恶性MCN,AUC 0.97。
  • 无强化分隔或壁、壁厚<3mm、无壁结节对良性MCN阴性预测值高(97%-100%)。
  • MRI可用于MCN治疗前评估,辅助制定治疗策略。

核心结论

  • 联合4个MRI特征可提示恶性MCN,而薄且无强化的壁且无壁结节提示良性MCN。

研究设计与样本

  • 回顾性单中心研究,连续纳入63例切除的MCN患者(62例女性,98%),共63个MCN(6个恶性,2个高级别异型增生)。
  • MRI由两名阅片者独立评估,盲于病理结果,参考标准为病理诊断。

关键影像表现/征象

  • MRI特征包括T2WI信号不均匀、壁厚≥5mm、壁结节≥9mm、强化分隔。

诊断标准与关键数值

  • 联合T2WI信号不均匀、壁厚≥5mm、壁结节≥9mm、强化分隔诊断恶性MCN的AUC为0.97(95%CI 0.91-1.00)。
  • 63个MCN中,分别有24个(37%)、20个(32%)、10个(16%)、5个(8%)、4个(6%)具有0、1、2、3、4个上述特征。
  • 对应恶性MCN发生率分别为0%、0%、10%、20%、100%,阅片者间一致性良好至优秀。
  • 无强化分隔或壁的阴性预测值分别为97%和100%,壁厚<3mm的阴性预测值为100%,无壁结节的阴性预测值为100%。

临床应用与阅片要点

  • MRI可用于MCN治疗前评估,帮助确定治疗策略。
  • 阅片时注意评估T2WI信号均匀性、壁厚度、壁结节大小及分隔强化,以提示或排除恶性。

局限性

  • 回顾性单中心研究,样本量较小(63例),恶性病例少(6例恶性,2例高级别异型增生)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the value of MRI in differentiating benign (b-MCN) and malignant (m-MCN) MCN. European guidelines suggest that certain mucinous cystic neoplasms (MCN) of the pancreas can be conservatively managed.

METHODS: A retrospective single-center study of consecutive patients with resected MCN. MRIs were independently reviewed by two readers blinded to the pathological results. The authors compared b-MCN (i.e., mucinous-cystadenoma comprising high-grade dysplasia (HGD)) and m-MCN (i.e., cystadenocarcinoma).

RESULTS: Sixty-three patients (62 women [98%]) with 63 MCN (6 m-MCN, 2 HGD) were included. m-MCN tumors had a tendency to be larger than b-MCN (median 86 [25-103] vs. 45 [17-130] mm, p = .055). The combination of signal heterogeneity on T2-weighted imaging, wall thickness ≥ 5 mm, the presence of mural nodules ≥ 9 mm, and enhancing septa had an area under the ROC curve of 0.97 (95% CI 0.91-1.00) for the diagnosis of m-MCN. A total of 24 (37%), 20 (32%), 10 (16%), 5 (8%), and 4 (6%) out of 63 MCNs showed 0, 1, 2, 3, and 4 of these features, respectively. The corresponding rate of m-MCN was 0%, 0%, 10%, 20%, and 100%, respectively, with a good-to-excellent inter-reader agreement. Patterns with a high NPV for m-MCN included an absence of enhancing septa or walls (NPV 97% and 100%, respectively), wall thickness < 3 mm (NPV 100%), and no mural nodules (NPV 100%).

CONCLUSIONS: A combination of 4 imaging features suggests malignant MCN on MRI. On the other hand, visualization of a thin non-enhancing wall with no mural nodules suggests benign MCN.

KEY POINTS: • A heterogenous signal on T2-weighted MRI, a ≥ 5-mm-thick wall, mural nodules ≥ 9 mm, and/or enhancing septa suggest malignant MCNs. • A thin non-enhancing wall with no mural nodules suggests benign MCNs. • MRI should be performed in the pre-therapeutic evaluation of MCN to help determine the therapeutic strategy in these patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Vullierme MP, Gregory J, Rebours V, et al. MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas. Eur Radiol. 2021. PMID: 34374801. doi:10.1007/s00330-021-08091-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。